Seviterahct Tablet 5/40/12.5 Milligrams

Adult dose

This medication is taken as 1 tablet once daily with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The maximum dosing capacity is Amlodipine/Olmesartan Medoxomil/Hydrochlorothiazide of 10/40/25 mg. Adjust the dosage taking into account the blood pressure response at intervals of more than 2 weeks. The recommended dosages are as follows. - 5/20/12.5mg: Administered when blood pressure is not adequately controlled with Amlodipine/Olmesartan Medoxomil 5/20 mg combination therapy.

Child dose

The safety and efficacy in pediatric patients under 18 years of age have not been established; therefore, the administration of this medication is not recommended.

This drug may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be stopped immediately upon confirmation of pregnancy. This drug is contraindicated in patients with allergies to this drug or its components, as well as those with certain heart, kidney, or liver diseases, pregnant and nursing women, and patients with certain electrolyte abnormalities. Do not administer to patients with very low blood pressure, acute heart failure, severe liver dysfunction, or kidney dysfunction. Patients with reduced blood volume or those sensitive to changes in kidney function should be closely monitored before administration and appropriate measures taken if necessary. This drug should be used with caution in patients with impaired kidney function, those with specific cardiac valve diseases, liver dysfunction, and elderly patients. Since this drug lowers blood pressure, caution should be taken as dizziness or drowsiness may occur when driving or operating machinery. During the administration of this drug, serum electrolyte concentrations and kidney function should be regularly monitored to ensure no abnormalities are present. This drug may interact with other medications, especially when taken with lithium, non-steroidal anti-inflammatory drugs, or other antihypertensives, so consultation with a physician or pharmacist is necessary. Use should be avoided during pregnancy as it may pose risks to the fetus, and lactating women may need to stop breastfeeding or discontinue the drug as its ingredients can be transferred through breast milk. Safety and efficacy in pediatric patients have not been established, so its use is not recommended. In case of overdose, symptoms like hypotension, palpitations, and bradycardia may occur, and immediate medical attention should be sought for appropriate treatment. This drug should be stored in a cool, dry place away from moisture and heat, and kept out of reach of children.

Serious side effects

Hives, severe swelling (edema), chest discomfort, difficulty breathing, cold sweat, pallor, severe rash with fever, blistering, peeling skin, mouth/eye mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory problems accompanied by coughing and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion of consciousness, visual disturbances, paralysis, death.

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This drug may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the medication's effectiveness.

Appearance

Pale yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2)/ carton